Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125809151 | 12580915 | 1 | I | 20160523 | 20160721 | 20160721 | EXP | JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-042036 | BRISTOL MYERS SQUIBB | 0.00 | F | Y | 0.00000 | 20160721 | PH | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125809151 | 12580915 | 1 | PS | ABILIFY | ARIPIPRAZOLE | 1 | Unknown | 3 MG, UNK | U | 21436 | 3 | MG | TABLET | ||||||
| 125809151 | 12580915 | 2 | SS | ABILIFY | ARIPIPRAZOLE | 1 | Oral | 96 MG, (6 MG X 16 TABS) SINGLE | U | 21436 | 96 | MG | TABLET | ||||||
| 125809151 | 12580915 | 3 | SS | ZOPICLONE | ZOPICLONE | 1 | Oral | 100 MG, (10 MG X 10 TABS) SIINGLE | U | 0 | 100 | MG | TABLET | QD | |||||
| 125809151 | 12580915 | 4 | SS | DEPAKENE | VALPROIC ACID | 1 | Oral | 11600 MG, (200 MG X 58 TABLETS) | U | 0 | 11600 | MG | TABLET | QD | |||||
| 125809151 | 12580915 | 5 | SS | JZOLOFT | SERTRALINE HYDROCHLORIDE | 1 | Oral | 400 MG, (25 MG X 16 TABS) SINGLE | U | 0 | 400 | MG | TABLET | QD | |||||
| 125809151 | 12580915 | 6 | SS | REFLEX | MIRTAZAPINE | 1 | Oral | 240 MG (15 MG X 16 TABS) SINGLE | U | 0 | 240 | MG | TABLET | QD | |||||
| 125809151 | 12580915 | 7 | SS | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | Oral | 50 MG (25 MG X 2 TABS) SINGLE | U | 0 | 50 | MG | TABLET | QD | |||||
| 125809151 | 12580915 | 8 | SS | BELSOMRA | SUVOREXANT | 1 | Oral | 320 MG (20 MG X 16 TABS) | U | 0 | 320 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125809151 | 12580915 | 1 | Depression |
| 125809151 | 12580915 | 3 | Product used for unknown indication |
| 125809151 | 12580915 | 4 | Product used for unknown indication |
| 125809151 | 12580915 | 5 | Product used for unknown indication |
| 125809151 | 12580915 | 6 | Product used for unknown indication |
| 125809151 | 12580915 | 7 | Product used for unknown indication |
| 125809151 | 12580915 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125809151 | 12580915 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125809151 | 12580915 | Altered state of consciousness | |
| 125809151 | 12580915 | Asthenia | |
| 125809151 | 12580915 | Intentional overdose | |
| 125809151 | 12580915 | Sedation | |
| 125809151 | 12580915 | Toxicity to various agents |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |